The Impact of Direct-to-Consumer Pharmaceutical Advertising on Public Knowledge of Gastroesophageal Reflux Disease: A Study on Over-the-Counter Proton Pump Inhibitors
Maram AlShammari,1 Ghadah Assiri,1 Mohammed bin Buraykan,1 Yasser Almogbel,2 Azher Arafah,1,3 Adel Bashatah,4 Yazed AlRuthia1,5 1Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia; 2Department of Pharmacy Practice, College of Pharmacy, Qassim University,...
Main Authors: | AlShammari M, Assiri G, bin Buraykan M, Almogbel Y, Arafah A, Bashatah A, AlRuthia Y |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-03-01
|
Series: | Patient Preference and Adherence |
Subjects: | |
Online Access: | https://www.dovepress.com/the-impact-of-direct-to-consumer-pharmaceutical-advertising-on-public--peer-reviewed-article-PPA |
Similar Items
-
Effect of Proton Pump Inhibitors in Bronchiectatic Patients with Gastroesophageal Reflux Disease
by: Byungkyu Ahn, et al.
Published: (2016-07-01) -
Gastroesophageal reflux disease: exaggerations, evidence and clinical practice
by: Cristina Targa Ferreira, et al.
Published: (2014-03-01) -
Risk factors associated with gastroesophageal reflux disease relapse in primary care patients successfully treated with a proton pump inhibitor
by: A. López-Colombo, et al.
Published: (2017-04-01) -
Gastroesophageal reflux in children
by: Badriul Hegar, et al.
Published: (2011-12-01) -
Contemporary Approaches to the Treatment of Gastroesophageal Reflux Disease
by: Boris D. Starostin
Published: (2019-03-01)